Swiftly Meds Private Limited

Bdfoie 10 mg Capsules (Lenvatinib)

Active Ingredient: Lenvatinib (10 mg per capsule)

Description:

Bdfoie 10 mg Capsules contain Lenvatinib, a medication primarily used for the treatment of various types of cancer. Lenvatinib works as a tyrosine kinase inhibitor (TKI) that blocks certain proteins (kinases) involved in the growth of cancer cells and the development of blood vessels that supply tumors with nutrients. By inhibiting these enzymes, Lenvatinib helps to slow or stop the growth of cancer cells and tumor progression.

Lenvatinib is used to treat:

• Thyroid cancer (differentiated thyroid cancer)

• Hepatocellular carcinoma (liver cancer)

• Renal cell carcinoma (kidney cancer)

• Endometrial carcinoma (in combination with other chemotherapy treatments)

Dosage:

• Adults: The typical dose is 10 mg once daily for most conditions, but the exact dose and frequency depend on the type of cancer being treated and individual factors like tolerance and response.

• The medication can be taken with or without food.

• Your doctor may adjust your dose based on how you respond to treatment or if side effects occur.

Storage:

• Temperature: Store at room temperature (between 15°C to 30°C).

• Keep in original packaging: To protect the capsules from light and moisture, always store them in the packaging they came in.

• Out of reach of children: Ensure that the medication is stored safely to prevent accidental ingestion by children.

• Do not use beyond expiration date: Ensure to discard any expired medication.

Precautions:

• Health Conditions: Inform your doctor of any existing conditions, particularly heart disease, high blood pressure, liver problems, bleeding disorders, or any other health issues.

• Pregnancy and breastfeeding: Lenvatinib is not recommended during pregnancy as it may harm the fetus. You should not breastfeed while using this medication, as it may pass into breast milk.

• Monitoring: Regular monitoring of blood pressure, liver function, and thyroid function is typically required during treatment with Lenvatinib.

Possible Side Effects:

While Lenvatinib is generally well-tolerated, it may cause side effects. Some common ones include:

• Hypertension (high blood pressure)

• Fatigue

• Diarrhea

• Loss of appetite

• Hand-foot syndrome (redness, swelling, or pain on hands and feet)

• Weight loss

• Nausea and vomiting

Serious side effects could also occur, such as:

• Heart-related issues (e.g., heart failure, arrhythmias)

• Severe bleeding

• Liver problems (e.g., jaundice, liver failure)

If any side effects are severe or persistent, you should seek medical advice immediately.

Important Notes:

• Always follow your healthcare provider's instructions and attend regular check-ups while on treatment.

• If you miss a dose, take it as soon as you remember, unless it’s close to your next scheduled dose. Do not double the dose.

• Inform your doctor about any other medications you're taking to avoid potential drug interactions

 

Primcyv 100 mg Capsules - Product Description

Brand Name: Primcyv
Generic Name: Cilnidipine
Strength: 100 mg
Dosage Form: Capsule

Introduction: Primcyv 100 mg Capsules are a medication primarily used in the treatment of hypertension (high blood pressure). The active ingredient, cilnidipine, is a calcium channel blocker that works by relaxing and widening blood vessels, thereby lowering blood pressure and improving overall cardiovascular function. Primcyv 100 mg Capsules are an essential part of the management plan for patients with essential hypertension or other related cardiovascular conditions.

Mechanism of Action: Cilnidipine, the active component of Primcyv, belongs to the class of dihydropyridine calcium channel blockers. It works through dual mechanisms:

1. L-type Calcium Channel Blockade: Cilnidipine inhibits calcium influx into vascular smooth muscle and cardiac muscle cells, causing vasodilation. This helps to lower blood pressure by relaxing the blood vessels.
2. N-type Calcium Channel Blockade: It also inhibits N-type calcium channels in sympathetic nerve endings, reducing the release of norepinephrine and preventing excessive vasoconstriction. This helps to reduce systemic vascular resistance.

These dual effects contribute to effective blood pressure control with fewer side effects compared to some other calcium channel blockers.

Indications: Primcyv 100 mg Capsules are indicated for:

• Hypertension (High Blood Pressure): It is used in the management of both primary (essential) hypertension and secondary hypertension due to other underlying health conditions.
• Angina (Chest Pain): In some cases, cilnidipine may also be used to manage certain types of angina, although this is less common.

Dosage and Administration:

• The recommended starting dose of Primcyv 100 mg Capsules is typically 1 capsule once daily.
• The dosage may be adjusted depending on the patient's response and the severity of the condition.
• It is recommended to take the capsule at the same time each day for better adherence to the treatment plan.
• The capsules should be swallowed whole with a glass of water, with or without food.

Side Effects: Common side effects of Primcyv may include:

• Headache
• Dizziness
• Fatigue
• Palpitations
• Swelling in the lower limbs (edema)
• Flushing

Severe reactions are rare but may include hypotension (low blood pressure) or arrhythmias. If any unusual symptoms or signs of a severe allergic reaction occur, such as swelling of the face or difficulty breathing, immediate medical attention should be sought.

Precautions:

• Pregnancy and Breastfeeding: It is essential to inform the doctor if the patient is pregnant, planning to become pregnant, or breastfeeding, as the safety of cilnidipine in these situations has not been conclusively established.
• Kidney or Liver Impairment: Use with caution in patients with severe liver or kidney problems, as these conditions may affect the medication's metabolism and clearance.
• Drug Interactions: Cilnidipine may interact with other antihypertensive medications or certain other drugs, potentially increasing the risk of side effects or altering effectiveness. Consult a healthcare provider before starting any new medications.

Storage:

• Store in a cool, dry place at room temperature, away from moisture and direct sunlight.
• Keep out of reach of children.

 

 

Palbo 75 mg Capsule (Generic Name: Palbociclib 75 mg) is a prescription medication used for the treatment of HR-positive, HER2-negative breast cancer. Each capsule contains 75 mg of Palbociclib, a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor. Palbo is typically prescribed in combination with aromatase inhibitors like letrozole to manage metastatic or early-stage breast cancer, improving progression-free survival and enhancing overall treatment outcomes.

Key Benefits:

• Slows Cancer Cell Growth: Palbo works by inhibiting CDK4/6 proteins, which are essential in regulating cell division. By blocking these proteins, it slows the growth of HR-positive, HER2-negative breast cancer cells.

• Improves Survival Rates: When used in combination with aromatase inhibitors, Palbo has shown to significantly improve progression-free survival in patients with metastatic and early-stage breast cancer, contributing to enhanced treatment efficacy.

• Reduces Metastasis: By controlling cell division, Palbo helps prevent the spread (metastasis) of HR-positive, HER2-negative breast cancer to other parts of the body.

How Palbo Works:

Each 75 mg capsule of Palbo contains Palbociclib, a selective CDK4/6 inhibitor that targets key proteins responsible for cancer cell division. By inhibiting these proteins, Palbo slows the proliferation of cancer cells, making it an effective treatment option for controlling HR-positive, HER2-negative breast cancer.

Dosage Instructions:

The recommended dosage for Palbo 75 mg Capsule is one capsule per day for 21 consecutive days, followed by a 7-day break. Treatment cycles may vary depending on individual response to therapy, so it is essential to follow your healthcare provider's instructions for dosage and schedule.

Side Effects:

Common side effects of Palbo include nausea, fatigue, diarrhea, hair thinning, and low blood cell counts (especially neutropenia), which can increase the risk of infections. Serious side effects may include liver toxicity, lung problems, and severe infections. If you experience fever, chills, or unusual bruising or bleeding, contact your healthcare provider immediately.

Who Should Use Palbo:

• Adults diagnosed with HR-positive, HER2-negative breast cancer.

• Patients with metastatic or early-stage breast cancer requiring combination therapy for disease control.

• Individuals prescribed Palbo following a detailed evaluation by their healthcare provider.

Caution:

• Liver Function: Use Palbo cautiously in patients with liver conditions as it may affect liver function.

• Pregnancy: Palbo is contraindicated during pregnancy and should not be used by pregnant women. Effective contraception should be used during treatment and for at least one month after stopping Palbo.

• Immune System: Avoid live vaccines during treatment with Palbo, as it may weaken the immune system.

Storage Instructions:

• Store Palbo 75 mg Capsules at room temperature, between 15°C and 30°C (59°F to 86°F).

• Keep in a tightly closed container, away from light, moisture, and heat.

• Keep out of reach of children.

Adcilib 100 mg Capsule (Generic Name: Palbociclib 100 mg) is a prescription medication used to treat HR-positive, HER2-negative breast cancer. Each capsule contains 100 mg of Palbociclib, a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor. Adcilib is commonly prescribed in combination with aromatase inhibitors such as letrozole, helping manage metastatic or early-stage breast cancer, significantly improving progression-free survival and providing better treatment outcomes.

Key Benefits:

• Inhibits Cancer Growth: Adcilib targets and inhibits CDK4/6 proteins, which regulate the cell cycle and contribute to the uncontrolled growth of cancer cells. By blocking these proteins, Adcilib helps slow down the growth of HR-positive, HER2-negative breast cancer cells.

• Improves Survival Rates: When combined with aromatase inhibitors, Adcilib significantly improves progression-free survival in patients with metastatic or early-stage breast cancer, leading to better long-term results.

• Reduces the Risk of Metastasis: By controlling the cell cycle, Adcilib reduces the risk of cancer cells spreading (metastasizing) to other parts of the body, preventing further complications.

How Adcilib Works:

Each 100 mg capsule of Adcilib contains Palbociclib, a selective CDK4/6 inhibitor. CDK4/6 proteins play a crucial role in regulating the cell cycle. By inhibiting these proteins, Adcilib slows down cancer cell division and reduces the likelihood of metastasis, offering a crucial treatment option for HR-positive, HER2-negative breast cancer.

Dosage Instructions:

The recommended dosage of Adcilib 100 mg Capsule is one capsule per day for 21 consecutive days, followed by a 7-day break. The treatment cycle may be adjusted depending on individual patient needs and response to therapy. Always follow your healthcare provider’s dosage instructions for optimal results.

Side Effects:

Common side effects of Adcilib include nausea, fatigue, diarrhea, hair thinning, and low blood cell counts (especially neutropenia), which can increase the risk of infections. Serious side effects may include liver toxicity, lung issues, and severe infections. Contact your healthcare provider immediately if you experience fever, chills, or unusual bruising or bleeding.

Who Should Use Adcilib:

• Adults diagnosed with HR-positive, HER2-negative breast cancer.

• Patients with metastatic or early-stage breast cancer who require combination therapy to control disease progression.

• Individuals prescribed Adcilib following a thorough evaluation by their healthcare provider.

Caution:

• Liver Function: Use Adcilib with caution in patients with liver conditions, as it may affect liver function.

• Pregnancy: Adcilib is contraindicated during pregnancy and should not be used by pregnant women. Effective contraception should be used during treatment and for at least one month after discontinuing Adcilib.

• Immune System: Avoid live vaccines during treatment with Adcilib, as it may suppress the immune system.

Storage Instructions:

• Store Adcilib 100 mg Capsules at room temperature, between 15°C and 30°C (59°F to 86°F).

• Keep in a tightly closed container, away from light, moisture, and heat.

• Keep out of reach of children.

Cabotres 20 mg Tablets contain Cabozantinib, an oral medication used in the treatment of various types of cancer. It is a tyrosine kinase inhibitor that works by blocking certain proteins involved in the growth and spread of cancer cells.

Generic Name:

• Cabozantinib (Brand name: Cabotres)

Uses:

• Advanced or Metastatic Renal Cell Carcinoma (RCC): Cabotres is used to treat advanced or metastatic kidney cancer.
• Hepatocellular Carcinoma (HCC): It is also approved for the treatment of liver cancer in patients who have previously been treated with sorafenib.
• Medullary Thyroid Cancer (MTC): Cabotres can be used to treat medullary thyroid cancer in patients who have progressed despite prior therapy.

Benefits:

• Targeted Cancer Treatment: Cabotres blocks multiple pathways that are involved in tumor growth, blood vessel formation, and cancer spread.
• Improves Survival Rates: In certain cancers, it has been shown to extend survival by targeting the cancer’s ability to grow and spread.
• Reduces Tumor Growth: By inhibiting angiogenesis (formation of new blood vessels that supply tumors), Cabotres helps to reduce tumor size and progression.

Dosage and How to Take:

• Standard Dose: The usual dose is 20 mg once daily.
• Administration: Cabotres should be taken orally, with or without food. Swallow the tablet whole with a glass of water; do not crush or chew it.
• Missed Dose: If you miss a dose, take it as soon as you remember, but skip the missed dose if it's almost time for your next dose. Do not take two doses at once to make up for a missed dose.

Storage:

• Conditions: Store at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep in a dry place away from moisture and light.
• Keep out of reach of children.

Side Effects:

Common side effects include:

• Diarrhea: A common side effect, which can be managed with medications or diet changes.
• Fatigue: Some patients may experience tiredness or weakness.
• Hypertension (High Blood Pressure): Blood pressure should be monitored regularly during treatment.
• Mouth Sores: Some patients may develop mouth sores or ulcers.
• Liver Issues: Elevated liver enzymes or liver dysfunction may occur; regular monitoring is advised.
• Gastrointestinal Problems: Nausea, vomiting, or loss of appetite may occur.
• Bleeding: Cabotres may increase the risk of bleeding, including nosebleeds or gastrointestinal bleeding.

Precautions:

• Liver Function: Patients with liver disease should use Cabotres with caution, as it can affect liver function. Regular liver tests are recommended.
• Blood Pressure Monitoring: Since Cabotres may increase blood pressure, it is essential to monitor blood pressure regularly.
• Bleeding Risks: Patients at risk for bleeding should be carefully monitored, as Cabotres can increase bleeding risk.
• Pregnancy and Breastfeeding: Cabotres can harm an unborn baby and should not be used during pregnancy. It is also not recommended for breastfeeding.

Drug Interactions:

• Cytochrome P450 Enzyme Inhibitors/Inducers: Cabotres is metabolized by the liver, so drugs that affect liver enzymes can alter its effectiveness. Inform your doctor if you are taking medications such as antifungals, antibiotics, or anticonvulsants.
• Blood Thinners: Care should be taken when using blood thinners, as Cabotres may increase bleeding risk.

Spnib 50 mg Tablets: Description

Composition: Spnib 50 mg Tablets contain 50 mg of the active ingredient, Sertraline, which is classified as a selective serotonin reuptake inhibitor (SSRI). Each tablet also includes various excipients to aid in the tablet’s formation and stability.

Indications: Spnib 50 mg Tablets are prescribed for the treatment of various mental health conditions, including:

• Major Depressive Disorder (MDD): Used to alleviate symptoms of depression such as persistent sadness, lack of interest, fatigue, and feelings of worthlessness.
• Generalized Anxiety Disorder (GAD): Helps in reducing excessive anxiety and worry that is difficult to control, along with symptoms such as restlessness, fatigue, and irritability.
• Obsessive-Compulsive Disorder (OCD): Useful in managing unwanted, repetitive thoughts (obsessions) and behaviors (compulsions).
• Panic Disorder: Reduces the frequency and severity of panic attacks, characterized by sudden periods of intense fear and discomfort.
• Social Anxiety Disorder (SAD): Used to help with intense fear and avoidance of social situations.

Mechanism of Action: Spnib 50 mg Tablets work by selectively inhibiting the reuptake of serotonin, a neurotransmitter in the brain. By increasing serotonin levels in the synaptic cleft, Spnib helps to improve mood and reduce symptoms of anxiety, depression, and other related disorders.

Dosage and Administration:

• The recommended starting dose for adults is 50 mg per day, taken orally, usually in the morning or evening.
• The dose may be gradually increased by a healthcare provider depending on the patient's response and tolerability.
• Dosage adjustments may be necessary for patients with liver or kidney impairment, as well as for elderly patients.
• Spnib tablets should be swallowed whole with water and may be taken with or without food.

Contraindications: Spnib 50 mg Tablets should not be taken by individuals who:

• Are allergic to sertraline or any other component of the tablet.
• Are currently taking monoamine oxidase inhibitors (MAOIs) or have recently discontinued MAOI treatment (at least 14 days should elapse between stopping MAOIs and starting Spnib).
• Have a history of severe liver problems.

Precautions:

• Pregnancy and Breastfeeding: Consult your doctor before using Spnib if you are pregnant, planning to become pregnant, or breastfeeding. The drug may pass into breast milk and harm the baby.
• Suicidal Thoughts: SSRIs like Spnib may increase the risk of suicidal thoughts or behavior, especially in young adults and adolescents. Monitoring by a healthcare provider is essential.
• Serotonin Syndrome: Spnib should be used cautiously when combined with other drugs that increase serotonin levels, such as certain antidepressants, migraine medications, and herbal supplements (e.g., St. John's Wort).
• Discontinuation: Discontinuing Spnib should be done gradually under the supervision of a healthcare provider to reduce withdrawal symptoms.

Side Effects: Common side effects of Spnib 50 mg Tablets include:

• Gastrointestinal symptoms: Nausea, diarrhea, dry mouth.
• Central Nervous System: Headache, insomnia, dizziness, or drowsiness.
• Sexual Dysfunction: Decreased libido, delayed ejaculation, or anorgasmia.
• Other effects: Weight gain, tremor, or sweating.

Storage: Store Spnib 50 mg Tablets in a cool, dry place, away from direct sunlight. Keep the medication in its original packaging to protect it from moisture. Keep out of reach of children.

Nilocap 200 mg Capsules - Product Description

Nilocap 200 mg Capsules are a prescription medication used primarily for the management of various cardiovascular conditions. Containing the active ingredient Nifedipine, a calcium channel blocker, Nilocap works by relaxing the blood vessels and improving blood flow. This helps reduce blood pressure and alleviate symptoms associated with heart-related conditions, such as angina and hypertension.

Composition:

• Each capsule of Nilocap contains Nifedipine 200 mg as the active ingredient.

• Excipients (inactive ingredients) may include cellulose, starch, and magnesium stearate, depending on the specific formulation.

Indications: Nilocap 200 mg is used for the treatment and management of:

• Hypertension (High Blood Pressure): Helps lower blood pressure to reduce the risk of cardiovascular events.

• Angina Pectoris (Chest Pain): Relieves symptoms of chest pain by increasing blood flow to the heart.

• Other Cardiovascular Conditions: Can be prescribed for other heart-related disorders as determined by a healthcare provider.

Dosage: The typical starting dose for adults is one 200 mg capsule per day, taken orally. However, the exact dosage and frequency should always be determined by a doctor based on the individual's condition and response to treatment.

For individuals with severe hypertension or angina, the dosage may be adjusted. It's crucial to follow the doctor’s instructions precisely for optimal results. Do not exceed the prescribed dose unless directed by a healthcare professional.

Side Effects: As with any medication, Nilocap 200 mg may cause side effects. Some common side effects include:

• Headache

• Dizziness

• Flushing

• Swelling (edema) of the ankles or feet

• Nausea or upset stomach

If any severe side effects occur, it is important to seek immediate medical attention.

Contraindications: Nilocap should not be used by individuals who:

• Are allergic to Nifedipine or any other ingredients in the capsule.

• Have severe low blood pressure (hypotension).

• Suffer from uncontrolled heart conditions such as heart failure or severe aortic stenosis.

It is essential to consult a healthcare provider before using Nilocap if you have any history of liver disease, heart conditions, or are pregnant or breastfeeding.

Precautions:

• Monitor blood pressure regularly during treatment to avoid excessive lowering of blood pressure.

• Avoid alcohol while taking this medication as it can increase the risk of side effects like dizziness or fainting.

• Use with caution in patients with liver or kidney impairment.

Interactions: Nilocap may interact with other medications, including:

• Beta-blockers (used for heart conditions).

• Antifungal medications.

• Antibiotics.

• Other blood pressure medications.

Inform your doctor about all the medications you are currently taking to avoid potential drug interactions.

Storage:

• Store at room temperature (15-30°C).

• Keep the capsules away from moisture and light.

• Keep out of reach of children.